Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16670414 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
Condition: Hot Flashes
Interventions: Drug: Brisdelle (paroxetine mesylate);   Drug: Placebo capsules
2 Completed
Has Results
Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
Condition: Hot Flashes
Interventions: Drug: Brisdelle (paroxetine mesylate);   Drug: Sugar pill
3 Terminated Applied Relaxation for Vasomotor Symptoms
Conditions: Menopause;   Hot Flashes
Intervention: Behavioral: Applied Relaxation (AR)

Indicates status has not been verified in more than two years